DPP4 and type 2 diabetes mellitus: DPP4 rapidly converts glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) into an inactive form, causing a deficiency in insulin secretion commonly found in type 2 diabetes patients.